Compare OCGN & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | IIIV |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.8M | 427.0M |
| IPO Year | 2014 | 2018 |
| Metric | OCGN | IIIV |
|---|---|---|
| Price | $1.35 | $15.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $9.75 | ★ $33.20 |
| AVG Volume (30 Days) | ★ 3.2M | 488.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.05 |
| Revenue Next Year | $1,718.38 | $8.07 |
| P/E Ratio | ★ N/A | $69.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $15.57 |
| 52 Week High | $2.73 | $33.97 |
| Indicator | OCGN | IIIV |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 35.61 |
| Support Level | $1.29 | $15.59 |
| Resistance Level | $1.49 | $17.12 |
| Average True Range (ATR) | 0.06 | 0.67 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 28.57 | 18.00 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.